查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1810944

2025年莱姆病检测全球市场报告

Lyme Disease Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年莱姆病检测市场将强劲成长，到 2029 年将达到 151.1 亿美元，年复合成长率（CAGR）为 9.1%。预测期内的成长可归因于前往莱姆病流行地区的旅行增多、多重诊断技术的使用增多、户外休閒活动的激增、对家用检测套组的需求增长，以及对莱姆病与其他蜱传疾病共病的担忧日益加深。预测期内的主要趋势包括分子诊断技术的进步、生物标记发现的进展、就地检验设备的创新、实验室晶片（微流体）平台的发展以及免疫检测技术的改进。

蜱传疾病的日益流行预计将推动莱姆病检测市场的成长。蜱传疾病透过感染的蜱叮咬传播给人类，蜱传疾病是一种常见于草地、森林地区和农村地区的小型寄生虫。由于气候变迁导致蜱的地理分布不断扩大，导致接触率和感染率上升，对蜱传疾病治疗和检测的需求正在增长。由于蜱是莱姆病的主要媒介，此病的增加凸显了早期发现和准确诊断的必要性。例如，2024 年 7 月，美国联邦公共卫生机构疾病管制与预防中心 (CDC) 报告称，蜱传感染疾病病例数从 2021 年的 36,177 例增加到 2022 年的 71,346 例。因此，蜱传疾病病例的增加正在推动对莱姆病检测的需求。

莱姆病检测市场的公司正专注于诊断工具的创新，以提高检测准确性、缩短週转时间并支持疾病的早期发现。这些诊断工具包括设备、套件和技术，旨在透过检测与导致莱姆病的细菌伯氏疏螺旋体相关的抗体、抗原和遗传物质来识别莱姆病的存在。例如，2024 年 8 月，英国生物技术公司 EpitogenX Ltd. 推出了新的莱姆病诊断套件。这种基于 ELISA 的检测方法是使用该公司专有的 Epitogen 平台开发的，包含大约​​ 120 种不同的伯氏疏螺旋体表位，具有高特异性和灵敏度。此套件仅供研究使用 (RUO)，可实现早期、特异性菌株的检测，并适用于各种检测环境，从而提高诊断准确性并更深入地了解莱姆病。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球莱姆病检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球莱姆病检测市场：成长率分析
  • 全球莱姆病检测市场表现：规模与成长，2019-2024
  • 全球莱姆病检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球莱姆病检测：总目标市场（TAM）

第六章 市场细分

  • 全球莱姆病检测市场：按检测类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血清学检测
  • 核酸检测
  • 尿液抗原检测
  • 其他测试类型
  • 全球莱姆病检测市场：检测调查方法、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 西方印迹法
  • 聚合酵素链锁反应（PCR）
  • 萤光测定（IFA）
  • 其他新兴技术
  • 全球莱姆病检测市场：依疾病阶段、实际状况及预测，2019-2024 年、2024-2029 年、2034 年
  • 早期莱姆病
  • 播散性莱姆病
  • 慢性莱姆病
  • 检测无症状性莱姆病
  • 全球莱姆病检测市场（按样本类型）：实际值和预测值，2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 脑脊髓液（CSF）
  • 其他血液样本
  • 全球莱姆病检测市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 居家照护环境
  • 研究所
  • 公共卫生机构
  • 全球莱姆病检测市场：按血清学检测类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法
  • 蛋白质印迹法
  • 萤光测定（IFA）
  • 线免疫分析（LIA）
  • 全球莱姆病检测市场：依核酸检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 环介导等温扩增（LAMP）
  • 次世代定序（NGS）
  • 全球莱姆病检测市场：尿液抗原检测细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 横向流动化验
  • 酵素免疫分析法（EIA）
  • 免疫印迹尿液检查
  • 全球莱姆病检测市场：按检测类型、其他检测、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 基于文化的测试
  • 蜱传合併感染小组
  • 人工智慧辅助诊断工具

第七章 区域和国家分析

  • 全球莱姆病检测市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球莱姆病检测市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 莱姆病检测市场：竞争格局
  • 莱姆病检测市场：公司简介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • BIOMERIEUX
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • DiaSorin SpA
  • Meridian Bioscience
  • Everlywell
  • Trinity Biotech
  • T2 Biosystems
  • IGeneX
  • Viramed Biotech AG
  • Ceres Nanosciences
  • Galaxy Diagnostics
  • Novatein Biosciences
  • Lyme Diagnostics Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年莱姆病检测市场：提供新机会的国家
  • 2029 年莱姆病检测市场：细分市场带来新机会
  • 2029 年莱姆病检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37046

Lyme disease testing involves diagnostic methods used to identify infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, which is commonly transmitted via tick bites. The primary goal of Lyme disease testing is to ensure accurate diagnosis, particularly in individuals presenting symptoms such as fever, fatigue, and the distinctive bull's-eye rash.

The primary types of tests used in Lyme disease diagnostics include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests detect the presence of antibodies or antigens in a patient's blood to determine exposure to infections or immune responses. Common testing techniques include enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Testing is applicable across different disease stages, including early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic infection detection. Various sample types used include blood, urine, cerebrospinal fluid (CSF), and more. These diagnostic procedures are carried out by a range of end users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health agencies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides lyme disease testing market statistics, including lyme disease testing industry global market size, regional shares, competitors with a lyme disease testing market share, detailed lyme disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. The lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising demand for early disease diagnosis, increased accessibility to advanced diagnostic technologies, a growing tick population driven by climate change, enhanced government funding for the control of vector-borne diseases, and the expansion of healthcare infrastructure in rural and endemic regions.

The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth during the forecast period can be attributed to the rising travel to Lyme-endemic areas, increased utilization of multiplex diagnostic technologies, a surge in outdoor recreational activities, growing demand for at-home testing kits, and heightened concerns about co-infections with other tick-borne illnesses. Key trends expected in the forecast period include progress in molecular diagnostic methods, advancements in biomarker discovery, technological innovations in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) platforms, and improvements in immunoassay technologies.

The increasing prevalence of tick-borne illnesses is expected to drive the growth of the Lyme disease testing market. Tick-borne illnesses are diseases transmitted to humans through bites from infected ticks, which are small parasites commonly found in grassy, wooded, or rural areas. The demand for treatments and testing related to tick-borne illnesses is rising due to the expanding geographic distribution of ticks, largely influenced by climate change, resulting in greater exposure and infection rates. Since ticks are the primary vectors for Lyme disease, the increase in these illnesses highlights the need for early detection and accurate diagnosis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported 71,346 cases of tick-borne diseases in 2022-up from 36,177 cases in 2021. As a result, the growing number of tick-borne illness cases is fueling the demand for Lyme disease testing.

Companies in the Lyme disease testing market are emphasizing technological innovations in diagnostic tools to improve test accuracy, decrease turnaround times, and support early-stage disease detection. These diagnostic tools include devices, kits, and technologies designed to identify the presence of Lyme disease by detecting antibodies, antigens, or genetic material associated with Borrelia burgdorferi, the bacteria responsible for the disease. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, launched a new Lyme Disease Diagnostic Kit. This ELISA-based assay was developed using the company's proprietary EpitoGen platform and includes approximately 120 distinct Borrelia epitopes, offering high specificity and sensitivity. Designed for research use only (RUO), the kit enables early, strain-specific detection and can be adapted for various laboratory settings, providing enhanced diagnostic accuracy and deeper insights into Lyme disease.

In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics company, formed a partnership with ECO Laboratory to improve early Lyme disease detection. This collaboration focuses on advancing the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test aimed at providing accurate and early detection of Lyme disease. The partnership utilizes ECO Laboratory's CLIA-certified facilities to broaden access to advanced tick-borne disease testing throughout the United States. ECO Laboratory is a US-based diagnostic service provider specializing in Lyme and other tick-borne illnesses.

Major players in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMERIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, and Lyme Diagnostics Ltd.

North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lyme disease testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lyme disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lyme disease testing market includes revenues earned by entities by providing services such as diagnostic test kit development, laboratory testing services, polymerase chain reaction (PCR)-based testing, serological testing, and point-of-care testing solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyme Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lyme disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyme disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Serological Tests; Nucleic Acid Tests; Urine Antigen Tests; Other Test Types
  • 2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA); Weste Blot; Polymerase Chain Reaction (PCR); Immunofluorescence Assay (IFA); Other Emerging Technologies
  • 3) By Disease Stage: Early Lyme Disease; Disseminated Lyme Disease; Chronic Lyme Disease; Asymptomatic Lyme Disease Detection
  • 4) By Sample Type: Blood; Urine; Cerebrospinal Fluid(CSF); Other Blood Samples
  • 5) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Research Institutions; Public Health Organizations
  • Subsegments:
  • 1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
  • 2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
  • 3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
  • 4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific; BIOMERIEUX; Quidel Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A; Meridian Bioscience; Everlywell; Trinity Biotech; T2 Biosystems; IGeneX; Viramed Biotech AG; Ceres Nanosciences; Galaxy Diagnostics; Novatein Biosciences; Lyme Diagnostics Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lyme Disease Testing Market Characteristics

3. Lyme Disease Testing Market Trends And Strategies

4. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lyme Disease Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lyme Disease Testing Market Growth Rate Analysis
  • 5.4. Global Lyme Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lyme Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lyme Disease Testing Total Addressable Market (TAM)

6. Lyme Disease Testing Market Segmentation

  • 6.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests
  • Nucleic Acid Tests
  • Urine Antigen Tests
  • Other Test Types
  • 6.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Weste Blot
  • Polymerase Chain Reaction (PCR)
  • Immunofluorescence Assay (IFA)
  • Other Emerging Technologies
  • 6.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Early Lyme Disease
  • Disseminated Lyme Disease
  • Chronic Lyme Disease
  • Asymptomatic Lyme Disease Detection
  • 6.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Cerebrospinal Fluid(CSF)
  • Other Blood Samples
  • 6.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Institutions
  • Public Health Organizations
  • 6.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay
  • Western Blot
  • Immunofluorescence Assay (IFA)
  • Line Immunoassay (LIA)
  • 6.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Next-Generation Sequencing (NGS)
  • 6.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Assay
  • Enzyme Immunoassay (EIA)
  • Immunoblot Urine Tests
  • 6.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture-Based Tests
  • Tick-Borne Co-Infection Panels
  • Artificial Intelligence-Assisted Diagnostic Tools

7. Lyme Disease Testing Market Regional And Country Analysis

  • 7.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lyme Disease Testing Market

  • 8.1. Asia-Pacific Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lyme Disease Testing Market

  • 9.1. China Lyme Disease Testing Market Overview
  • 9.2. China Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lyme Disease Testing Market

  • 10.1. India Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lyme Disease Testing Market

  • 11.1. Japan Lyme Disease Testing Market Overview
  • 11.2. Japan Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lyme Disease Testing Market

  • 12.1. Australia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lyme Disease Testing Market

  • 13.1. Indonesia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lyme Disease Testing Market

  • 14.1. South Korea Lyme Disease Testing Market Overview
  • 14.2. South Korea Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lyme Disease Testing Market

  • 15.1. Western Europe Lyme Disease Testing Market Overview
  • 15.2. Western Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lyme Disease Testing Market

  • 16.1. UK Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lyme Disease Testing Market

  • 17.1. Germany Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lyme Disease Testing Market

  • 18.1. France Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lyme Disease Testing Market

  • 19.1. Italy Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lyme Disease Testing Market

  • 20.1. Spain Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lyme Disease Testing Market

  • 21.1. Eastern Europe Lyme Disease Testing Market Overview
  • 21.2. Eastern Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lyme Disease Testing Market

  • 22.1. Russia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lyme Disease Testing Market

  • 23.1. North America Lyme Disease Testing Market Overview
  • 23.2. North America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lyme Disease Testing Market

  • 24.1. USA Lyme Disease Testing Market Overview
  • 24.2. USA Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lyme Disease Testing Market

  • 25.1. Canada Lyme Disease Testing Market Overview
  • 25.2. Canada Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lyme Disease Testing Market

  • 26.1. South America Lyme Disease Testing Market Overview
  • 26.2. South America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lyme Disease Testing Market

  • 27.1. Brazil Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lyme Disease Testing Market

  • 28.1. Middle East Lyme Disease Testing Market Overview
  • 28.2. Middle East Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lyme Disease Testing Market

  • 29.1. Africa Lyme Disease Testing Market Overview
  • 29.2. Africa Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lyme Disease Testing Market Competitive Landscape And Company Profiles

  • 30.1. Lyme Disease Testing Market Competitive Landscape
  • 30.2. Lyme Disease Testing Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Lyme Disease Testing Market Other Major And Innovative Companies

  • 31.1. BIOMERIEUX
  • 31.2. Quidel Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. QIAGEN N.V.
  • 31.5. DiaSorin S.p.A
  • 31.6. Meridian Bioscience
  • 31.7. Everlywell
  • 31.8. Trinity Biotech
  • 31.9. T2 Biosystems
  • 31.10. IGeneX
  • 31.11. Viramed Biotech AG
  • 31.12. Ceres Nanosciences
  • 31.13. Galaxy Diagnostics
  • 31.14. Novatein Biosciences
  • 31.15. Lyme Diagnostics Ltd.

32. Global Lyme Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lyme Disease Testing Market

34. Recent Developments In The Lyme Disease Testing Market

35. Lyme Disease Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Lyme Disease Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lyme Disease Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lyme Disease Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer